Laboratory monitoring of nusinersen safety

Keyphrases

• Laboratory Monitoring 100%
• Nusinersen 100%
• Spinal muscular Atrophy 33%
• Intrathecal 33%
• General Anesthesia 33%
• Fluoroscopic Guidance 33%
• Anxiolysis 33%
• Increased Intracranial Pressure 16%
• Tertiary Care Hospital 16%
• Adverse Events 16%
• Serious Adverse Events 16%
• Sedation 16%
• Procedural Sedation 16%
• Laboratory Abnormalities 16%
• Proteinuria 16%
• Spine 16%
• Safety Monitoring 16%
• Intubation 16%
• Center Experience 16%
• Treatment-related 16%
• Oral Midazolam 16%
• Emesis 16%
• Laboratory Results 16%
• Fluoroscopy-guided 16%
• Spinal muscular Atrophy Type I 16%

Pharmacology, Toxicology and Pharmaceutical Science

• Nusinersen 100%
• Adverse Event 33%
• Intrathecal 33%
• Spinal Muscular Atrophy 33%
• Retrospective Study 16%
• Intubation 16%
• Proteinuria 16%
• Vomiting 16%
• Midazolam 16%
• Intracranial Hypertension 16%
• Werdnig Hoffmann Disease 16%